Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Net Income 2020–2023
Gain Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2023. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Gain Therapeutics Inc. net income for the quarter ending March 31, 2023 was -5.1 M, a 56.98% increase year-over-year.
- Gain Therapeutics Inc. net income for the twelve months ending March 31, 2023 was -18.2 M, a 147.23% increase year-over-year.
- Gain Therapeutics Inc. annual net income for 2023 was -22.3 M, a 26.59% increase from 2022.
- Gain Therapeutics Inc. annual net income for 2022 was -17.6 M, a 26.64% increase from 2021.
- Gain Therapeutics Inc. annual net income for 2021 was -13.9 M, a 288.26% increase from 2020.
- Gain Therapeutics Inc. annual net income for 2020 was -3.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gain Therapeutics Inc. Net Income — FAQ
Gain Therapeutics Inc. (GANX) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Gain Therapeutics Inc.'s net income?
Gain Therapeutics Inc. (GANX) reported net income of -$22M for fiscal 2023.
Where can I see GANX's net income history?
The chart and table above show Gain Therapeutics Inc.'s net income by year and by quarter, including the growth rate.